More on ELOX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.2 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Eloxx Pharmaceuticals (NQ:ELOX)
Delayed: 15.75 -0.53 (3.26%)
Prev. Close $16.28  
Open$16.74 
52 Wk High$ 
52 Wk Low$ 
Day High$17.19 
Day Low$15.00 
P/E N/A  
EPS$ 
Volume17,170 

Friends, Peers and Foes (?): ELOXD (more...)

Sep 11, 2026 05:29 PM Form S-1 Eloxx Pharmaceuticals,
Sep 11, 2026 07:30 AM Eloxx doses first patients in Phase 2b Alport syndrome trial
Sep 11, 2026 07:30 AM Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
Aug 20, 2026 06:05 AM Lucid Capital Markets Starts Eloxx Pharma (ELOX) at Buy
Aug 14, 2026 04:54 PM Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Samsara BioCapital, L.P.
Aug 14, 2026 04:44 PM Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Nantahala Capital Management, LLC
Aug 12, 2026 06:00 AM Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 11, 2026 05:20 PM Form 8-K Eloxx Pharmaceuticals, For: Aug 11
Aug 11, 2026 05:03 PM Form 10-Q Eloxx Pharmaceuticals, For: Jun 30
Jul 27, 2026 07:56 AM Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Aberdeen Group plc
View All Articles

Entities mentioned with ELOX

View All Entities